The following study tested the hypothesis that women with post-traumatic stress disorder (PTSD) related to childhood sexual abuse would display elevated norepinephrine-to-cortisol ratios similar to that found in male combat veterans diagnosed with PTSD. Twenty-four-hour urine samples were collected from 28 women: 11 women with PTSD who experienced childhood sexual abuse (PTSD+), 8 women who experienced childhood sexual abuse without PTSD (PTSD-], and 9 nonabused controls. All urine samples were tested for creatinine, total catecholamines, free-cortisol, and 17-ketosteroid levels. Psychological testing validated that the PTSD+ group was significantly elevated on all three subscales of the Impact of Events Scale. Both abused groups (PTSD+ and PTSD-) showed a tendency for polyuria, and the PTSD+ group showed a tendency towards obesity. Thus, neuroendocrine values (/j.g/day) were adjusted by creatinine clearance rates (creatinine mg/day/kg body weight). The corrected values indicated that the PTSD+ group had significantly elevated daily levels of norepinephrine, epinephrine, dopamine, and cortisol. However, because of the parallel elevation in cortisol, the norepinephrine-to-cortisol ratio was not significantly elevated in the PTSD+ diagnosed women in contrast to the findings reported for male PTSD patients. This discrepancy may reflect an important gender difference, an interaction between gender and age at onset of the traumatic experience (childhood abuse in females vs. combat experience in young adult males), or physiological variation related to phase of the disorder.
INTRODUCTION
Since its introduction to the DSM-III-R in 1980 (l), the validity of post-traumatic stress disorder (PTSD) as a unique clinical entity has been the subject of considerable debate and research. Perhaps some of the most convincing evidence supporting the differentiation of PTSD from either depression or other affective disorders has come from studies demonstrating a unique neuroendocrine profile in male combat veterans suffering from PTSD.
Mason and his colleagues were the first to demonstrate that PTSD may be distinguished from major depressive disorder, bipolar disorder, and schizophrenia on the basis of both urinary cortisol (2) and urinary catecholamine levels (3) . These early studies, and subsequent reports, suggested that PTSD patients exhibit a profile with elevated norepinephrine but low levels of urinary-free cortisol. This relationship between high catecholamines and low cortisol has been represented as a ratio of norepinephrine-to-cortisol (NE/C), and the index appears to be significantly higher in PTSD patients than in any of the other psychiatric groups tested (4) . Normal, and possibly enhanced, cortisol suppression after dexamethasone administration further supports the suggestion of below-normal cortisol output in this group (5. 6) .
Female victims of psychosocial trauma constitute an important, but understudied, group from the psychobiological perspective. Epidemiological studies have suggested that overall lifetime prevalence of PTSD within the general population is 1.3%, with nearly two-thirds of those diagnosed being women (7) . An increased incidence of PTSD has been demonstrated in a number of traumatized populations, including crime victims and civilian war victims (8) (9) (10) . Furthermore, adult survivors of childhood sexual abuse (CSA) typically meet the PTSD diagnosis at rates ranging from 25 to 62% (11) (12) (13) (14) (15) .
Although supportive of the use of the PTSD diagnosis in a CSA population, the cited studies have relied solely on structured clinical interviews and/or self-report psychological measures. Based on the current literature, there is virtually no information on the endocrine functioning of these patients as a distinct group. If women who manifest PTSD related to CSA display the same neuroendocrine profile as the male combat veteran, it would provide addi-tional support for the validity of the diagnosis for this population.
This study also extended the evaluation of adrenal physiology to include an assessment of the secretion of adrenal androgens. The adrenal cortex synthesizes both glucocorticoids and androgens, such as DHEA-S (16, 17) . Low levels of 17-ketosteroids (17-KS) the major metabolite of DHEA-S, in urine would support the hypothesis that the function of the adrenal cortex is down-regulated in PTSD, whereas high levels would be more indicative of general physiological activation.
There is also some indirect evidence that the endocrine profile of PTSD may be associated with reports of psychosomatic symptomatology and/or menstrual dysfunction. PTSD in the male combat veteran has been linked to a number of physical illnesses including cardiovascular disease, gastrointestinal symptoms, chronic pain, and rheumatism (10, 18, 19) . Similarly, sexually abused women are over-represented in treatment for premenstrual syndrome (20, 21) . Prior research has shown that abused women tend to score high on somatization and show an increased incidence of asthma, spastic colitis, dysmenorrhea, and other nonsurgical gynecological problems (22, 23) .
Additional health-related outcomes not reported in the PTSD literature have been linked to affective disorders. Serendipitous findings led us to consider excess urine production (polyuria) and obesity. Polyuria related to primary polydipsia, but unrelated to medication, has been documented in both psychotic patients and manic depressive patients (24, 25) . In addition to increased fluid consumption, there is some evidence of a link between a history of CSA and obesity in adulthood (26) (27) (28) . Although there is little literature addressing the occurrence of these outcomes in the PTSD literature, the link between obesity and CSA was suggestive enough to warrant consideration in the present study. We therefore investigated the possibility that polydipsia reflected in increased urine production and/or obesity may have been present within this sample of abused women diagnosed with PTSD.
METHODS

Subjects
Three groups of women were recruited to participate in the study: a) women who had experienced childhood sexual abuse and qualified for the PTSD diagnosis (PTSD+): b) women who experienced childhood sexual abuse, but were not currently diagnosed with PTSD (PTSD-); and c) age-comparable women who had not experienced childhood sexual abuse and who were not currently in psychotherapy (controls). Women with a history of CSA were recruited through a private therapy clinic. Female patients self-identified as sexual abuse survivors were given letters inviting them to participate in the study. Diagnosis of PTSD status was conducted by a master's-prepared social worker using a checklist based on the DSM-III-R criteria for PTSD (see Acknowledgment). The questions covered the points included within the reexperiencing, avoidance, and arousal criteria categories of the DSM-III-R. The self-report of childhood sexual abuse was used to fulfill the stressor criteria (criteria A). At least one symptom from the reexperiencing category, three from the avoidance category, and two from the arousal category were required for a PTSD+ diagnosis. The abused women were briefly interviewed, using the checklist to establish the diagnosis. The diagnosis was subsequently verified independently by a second clinician (AML).
Contact with the investigator was in all cases initiated by the subject. Control subjects were gathered from announcements posted throughout the University campus and community at large. Additional subjects in the PTSD-group were recruited through friends, significant others, or family members of participants.
The three groups did not differ statistically on the variables of age, income level, or relationship status. The overall mean age of the participants was 35.3 ± 6.3 years with a range of 26 to 52 years; the average income was S22,000 per year. Although the groups did not differ on mean weight, the weight range was quite large (range 102-400 pounds with mean of 160 ± 64.5 pounds). Fifty percent of the PTSD+ women (5 of 10 reporting weights) were greater than 20% above ideal body weight as compared to 25% of the PTSD-(2 of 8) and 22% of the controls (2 of 7).
Five of the eleven PTSD+ (45%) subjects were currently taking antidepressants, a variable that was analyzed separately and shown to have no effect on urinary hormone levels. Three of the women (one in each group) were currently being treated for hypertension, but, as with the antidepressants, analysis of this variable indicated that neither urine volume nor any of the urinary hormone levels were affected by the use of antihypertensive medications. None of the subjects were taking benzodiazepines or other anxiolytic medications. Mean weekly consumption of alcohol was low, and the PTSD+ group did not differ from either the PTSD-nor the controls (mean = 1.7, 1.5, and 1.4 drinks/week, respectively).
Materials
Behavioral. All subjects were asked to complete three questionnaires focusing on the following three variables: a) PTSD symptom severity, b) general physical health status, and c) premenstrual symptom changes. The Impact of Events Scale (IES) is a 15-item self-report measure designed to quantify post-traumatic symptomatology in noncombat populations (29) . In addition to a total severity score, the IES also contains two subscales representing the two primary diagnostic behaviors of the disorder: intrusive behaviors and avoidance behaviors. Since the original crossvalidation studies in bereaved samples, the IES has been used to document PTSD severity in a number of traumatized samples, including physical trauma victims, rescue workers, crime victims, and survivors of terrorist attacks (30, 31, 32 , and 34 respectively). In the area of sexual assault, the IES has also been used to examine the acute response to rape (35) . The IES was chosen because it is
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the most widely used measure of PTSD severity in civilian trauma populations.
A health assessment was completed by all subjects using the Survey of Immunological and General Health questionnaire (SIGH; 36). The questionnaire was developed initially to survey health conditions that might reflect immune competence. Respondents indicate the existence of a variety of illnesses in either themselves or immediate family and report the frequency of a variety of illness conditions over the past 2-month and 12-month intervals. Illness categories include respiratory, viral or fungal infections, dermatological, and allergies. Finally, the number of days absent from school or work due to physical illness, as well as the use of prescription and nonprescription drugs, is also reported. The instrument has been used successfully in other projects (37) .
In addition to general health, we included a measure of menstrual variation and dysfunction. The Premenstrual Assessment Form (PAF) is a 95-item questionnaire on which women indicate the changes experienced across the menstrual cycle, with a focus on the premenstrual phase (38) . The PAF is further divided into 18 unipolar scales that can be used to classify women into Research Diagnostic Criteria (RDC)-based diagnostic categories or to report elevations within each category when diagnosis into discrete categories is not of interest (39) . On each of the 95 items, women indicate to what extent the symptom in question had changed from late follicular (2 weeks ago) until now (administered 7 days before menstruation) on a scale of 1 (no change/not applicable) to 6 (extreme change; severity is so different from usual state that it is very apparent to you or those who know you well). There are five PAF subscales related to physical symptom changes across the menstrual cycle, nine subscales related to alterations in mood and/or behavior in general terms, and four subscales specifically created to deal with various features of depression and anxiety. The four depression and anxiety subscales address anxiety features, endogenous depressive features, organic syndrome features, and atypical depressive features. A full description of the contents of each scale can be found in the work of Halbreich et al. (38) .
Endocrine. Urinary catecholamines were measured by high performance liquid chromatography (HPLC) at the University of Wisconsin Hospital and Clinics. Samples were run in single determinations with the addition of pooled standards. The interassay variability (coefficient of variation, c.v.) across 60 assays run at the time of this study is provided for both high and low standards. For norepinephrine, the c.v. for the high standard (136 lxg/L) was 4.0% and for the low standard was 1.6% (30 /xg/L). In the case of epinephrine, the c.v for the high standard (60 /Lig/L) was 3.5% and for the low standard was 6.2% (3.56 ju,g/L). Finally, the c.v for dopamine at the high standard (290 jxg/L) was 4.1% and at the low standard was 2.8% (168 /ng/L). Assays that exceed a c.v. of 10% are routinely rejected.
Urinary-free cortisol levels were determined with an iodinated ( l25 I) radioimmunoassay kit (Gammacoat, Incstar, Stillwater, MN). A standard curve from 1 to 60 ju.g/dl was generated from five standards; the lower sensitivity of the curve was 0.21 /ng/dl. Cortisol was extracted from the urine samples into methylene chloride. The values were highly correlated [r = .99) but predictably lower (48%) than unextracted cortisol determinations from the same specimens. The interassay c.v. for this assay was 6.1%; the intraassay c.v. for the duplicate samples in the single assay employed here was 3.8%.
The creatinine values were determined using a modified Jaffe reaction end point assay. Subject urine samples were run in duplicates of 200 /xl/well, a 100-jU.l solution of 0.02 M picric acid/0.365 M NaOH was added to both standards and samples. Creatinine standards were used to generate a reference curve and ranged from 0 to 2.0 mg/ml. After sitting in room temperature for 15 minutes, the microtiter plate was gently agitated for 1 minute. After a second 15-minute incubation at room temperature, the optical density was read at 500 nm. The interassay variability, monitored with a single pooled urine sample, averages 4.6%, and the intraassay c.v. for the duplicate samples run in this assay was 7.1%.
The 17-KS levels, a urine measure that correlates over 0.9 with serum DHEA-S levels (44, 17) , were measured using a commercial colorimetry kit (Sigma Diagnostics, St. Louis, MO). Using the Zimmerman reaction process, samples were hydrolyzed with concentrated HC1 and heat, extracted with methylene chloride, and developed using jn-dinitrobenzene (0.2% w/v) under an alkaline condition (tetramethylammonium hydroxide, 2.7 mol/L). DHEA standards (173 umol/L) were used in the calibration and calculation of the standard curve. Both standards and samples were read at 480 and 560 nm. A third 520-nm value was derived through interpolation. Total 17-KS (mg/24 hour) were calculated using the following formula: Ac TEST/Ac standard X 20 x total urine volume (L). Ac denotes the corrected absorbance where: 520-nm wavelength -(480 nm + 560 nm/2). The 17-KS values were determined from single specimens within one complete assay, and thus c.v. values were not computed.
Because it has been shown that under stress a subset of subjects will show a significant rise in urine flow rate without a concomitant rise in creatinine (40, 41) , we chose to analyze the endocrine parameters as both /u-g/day and as /xg/day corrected by creatinine output. Correcting for creatinine output as milligram of substance per day per kilogram of body weight (mg/24 hour/kg) is an index used to represent hormone values with respect to lean body mass and body weight. The following sections will refer to the /xg/day analysis as "'uncorrected analysis",and the /xg/day corrected by creatinine as the "corrected analysis." Procedure During the initial phone contact, all women were told that participation in the study would require the completion of a number of questionnaires and collection of a 24-hour urine sample timed to their menstrual cycle. It was explained that a range of questions would be asked concerning their general physical health, as well as current psychological functioning. Subjects were told that they would be paid for their participation ($15.00). All procedures were approved by the University of Wisconsin Human Subjects Committee.
After explaining all requirements of participation, initial interviews were set with those subjects agreeing to continue in the project. During this initial interview, subjects were provided with an information packet, two plastic 3-liter urine collection containers, and a urine collection pan with which to collect each void. Each packet contained the informed consent forms, printed urine collection instructions, and the following questionnaires: IES, SIGH, and PAF. Urine collection procedures were explained verbally to each subject, and subjects were shown the printed instructions contained within the packet. Subjects were told to complete the SIGH and the IES at their leisure but were instructed to wait until the urine collection date to complete the PAF. The abused subjects completed the IES with respect to the abuse they experienced as children, and the controls were asked to tliink of a "traumatic or highly upsetting experience that you remember from your own childhood." Examples of representative events
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include divorce of parents, seeing pet get hit by a car, or breaking a bone as a child.
The urine collection date was scheduled according to the premenstrual phase of their cycles (19-21 days after the first day of their last menses). Subjects were asked on the day of the urine collection to begin saving the urine after the first morning's void. Collection continued during the next 24 hours and included the following morning's first void. This schedule was to ensure that only one overnight sample was collected. Each urination was split equally between the two urine collection containers, one containing a HC1 additive and another not containing any preservative. Between urinations, the containers were kept refrigerated. In all cases, the total daily urine was quantified, and this volume measure permitted us to determine that some of the women excreted excessive amounts of urine. Polyuria is defined as a 24-hour urine volume exceeding 2500 ml (42) , and all subjects wore classified as polyuric based on this definition.
On receipt of the containers after the final urine collection, subjects were paid for their participation and given an opportunity to ask any further questions. Immediately on receipt, 50-ml aliquots of urine were sent for the catecholamine analysis (University of Wisconsin Hospitals and Clinics Laboratories). Further aliquots of urine were frozen at -70°C for later analysis. All cortisol, creatinine, glucose, and 17-KS assays were run on frozen samples as complete sets (all samples run on the same day). Cortisol and creatinine were measured using the nonacidified urine samples, whereas the 17-KS was measured using the acidified samples. Urinary glucose levels were also determined to exclude any diabetic subjects from the study. None of the samples were screened for any drug or illicit substance abuse.
Data Analysis
One way analysis of variance (ANOVA) tests with group (PTSD+, PTSD-, and controls) as an independent factor were conducted on each of the endocrine variables as well as the psychological variables. The choice of using ANOVA to analyze hormone values adjusted by creatinine and body weight, rather than using regression to covary these values, was based on the fact that we observed group differences in creatinine levels. Existing group differences precluded the use of a variable as a covariate (43) . Additional comparisons were conducted within the PTSD+ condition comparing those on antidepressants with those not on antidepressants. Where indicated, Scheffe post hoc tests were conducted to test significant differences between the three groups. Analysis of covariance tests (ANCOVA) were conducted to test for the possible contribution of depression on the physiological parameters. Chi-square analysis was conducted on all nominal data, such as illness incidence, polyuria incidence, and selfreported use of medications. Where expected frequency values fell below 5, Fisher's exact tests or Yates corrections were conducted as indicated. In all cases, the a level was set at 0.05.
RESULTS
Behavioral Profile
As seen in Table 1 , the women diagnosed as PTSD+ were elevated on all three measures of the IES. One way analysis of variance tests were significant for the intrusion subscale [F(2,25] = 8.10, p < . Post hoc analysis confirmed that the PTSD+ women were significantly different from the controls. The only subscale in which PSTD+ taking antidepressants differed from nonmedicated PTSD+ subjects was on the emotional lability subscale [£(7) = 2.4, p < .05]. Subjects on antidepressant medication scored higher on emotional lability than did the nonmedicated PTSD+ patients (mean = 14.5 and 7.6, respectively). In contrast, the PTSD-women Endocrine Profile Based on the accepted definition of polyuria, four of the PTSD+ women and two of the PTSD-abused women, but none of the control women, qualified as polyuric. When assessed as an abused population vs. a nonabused population, correlational analysis using the <\) coefficient suggested that there was a significant relationship between abuse history and polyuria (r = .36, p < .05). An increased incidence of polyuria in the abused population was further supported by the significant differences in urinary creatinine concentrations between the three groups [F(2,25) = 6.34, p < .01]. Post hoc testing indicated that the PTSD+ samples contained a lower concentration of creatinine than did the controls (mean = .88 and 1.57 mg/ml, respectively, Scheffe = 6.20, p < .05]. Urine volume and creatinine levels were not significantly affected by the use of either antidepressant or antihypertensive medications in this sample.
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The mean daily output of urine was 2231.4 ml in the PTSD+ subjects, 1758.8 ml in the PTSD-subjects, and 1191.7 ml in the controls. These differences approached, but did not achieve, statistical significance. Because excessive urination is associated with diabetes, and several of the subjects were obese, all urine samples were screened for glucose levels. None of the subjects evinced urinary glucose levels indicative of an undiagnosed diabetic condition. Although average body weight did not differ significantly across groups, it is clear that the weight range within the PTSD+ group was large (ranges: PTSD+ 102-400 lbs; PTSD-108-195 lbs; controls 120-170 lbs), indicating a need to consider weight as a variable. The daily excretion of both norepinephrine and dopamine were significantly correlated with body weight (r = .39, p < .05 and r = .46, p < .01, respectively. Neither epinephrine nor cortisol was significantly related to body weight (r = -.13 and v = .11, respectively). This issue was further emphasized by a variable relationship between creatinine and weight. Creatinine concentration (mg/ml) was not correlated with body weight (r = -.17), and the correlation between body weight and daily output of creatinine was significant but low (r = .33, p = .05).
The observation of a tendency for polyuria, large range in body weight, and low correlations between body weight and creatinine indicated that all of Psychosomatic Medicine 57:105-115 (1995) these variables needed to be taken into account when evaluating the hormone levels. For comparison, the daily hormone secretion has been reported in both the uncorrected and corrected forms; both sets of values can be seen in Table 3 .
Uncorrected analysis. Total daily output suggested a tendency for PTSD+ women to excrete higher levels of all measured hormones. High individual variation prevented the catecholamine and cortisol values from reaching statistical significance, but the differences in the level of androgenic metabolites approached significance [F(2,25) = 2.76, p < .08]. The androgenic metabolites were also significantly correlated with cortisol levels (r = .51, p < .05). Neither the use of antidepressants or antihypertensives was related to catecholamine values expressed as daily output.
Corrected analysis. The trend for higher catecholamine and cortisol excretion emerged as significant when considered with respect to creatinine and body weight. When /LLg/day of each endocrine value was corrected by creatinine and body weight, both catecholamine and cortisol levels in the PTSD+ women were elevated above nonabused controls. One-way ANOVA indicated significant group differences for norepinephrine [F(2,24) = 3.69, p < .05] and epinephrine [F(2,22) = 5.72, p < .01]. Post hoc analysis confirmed that the PTSD+ subjects were significantly elevated in comparison to the controls (p < .05), whereas the PTSD-subjects were not significantly different from either the controls or PTSD+ (Table 3 ). The pattern of results was also similar for dopamine, although nonsignificant [F(2,24) = 2.80, p < .08]. As with the uncorrected values, the androgenic metabolites were not statistically significant, although a trend for higher levels in the PTSD+ women was evident [F(2,24) = 2.73, p < .09].
The primary question concerned cortisol levels, however, and on this hormone measure, the PTSD+ women clearly differed from the pattern reported for males. Women diagnosed with PTSD had significantly elevated cortisol values [F(2,24) = 4.89, p < .05]. Post hoc analysis confirmed that the PTSD+ women were significantly different from both controls and the PTSD-women. The PTSD+ women also had elevated cortisol levels, so the resulting NE/C was not significantly different. Although the ratio was slightly higher in the PTSD+ women, neither the ratios derived from uncorrected or the creatinine-corrected values were significantly different. Androgenic metabolites correlated significantly with cortisol [r = .77, p < .01).
Given the evidence of a comorbidity with depression within the PSTD+ group, it was important to consider the possible impact of depressive symptoms on the endocrine values. Separate analyses of covariance (ANCOVAs) were conducted controlling for depressive symptomatology. Two PAF subscale measures of depression, endogenous depression scale and the organic depression scale, were chosen because they met the basic assumptions for the ANCOVA (47) . When both depression variables were controlled for in this manner, significant group dif- NE, norepinephrine; EPI, epinephrine; DA, dopamine. * All values in /xg/day corrected by concentration of creatinine (mg/ml) and body weight (kg). * p < 0.05; ** p < .01; significant differences between the PTSD+ and control groups. Comparisons were made based on medication status both within the full data set (all groups collapsed) and within the PTSD+ group alone. The use of antidepressants did not significantly affect norepinephrine, epinephrine, dopamine, or the ratio values in urine, although the PTSD+ subjects on antidepressants were significantly higher on both cortisol and adrenal androgens when compared to all other subjects [t{26) = -2.59; p < .05, and £(26) = -3.53, p < .01, respectively]. These analyses, however, compared the few subjects within the PTSD+ group who were using antidepressants to the remaining subjects from all three groups. When a t test was conducted for subjects within the PTSD+ group, neither cortisol nor the adrenal androgen was significantly different for those five women taking medications from those who were not. 
Correlations Between Neuroendocrine Activity and Psychological Variables
Correlational analyses between the endocrine and psychometric data suggested that there may be some merit to the argument for a unique contribution of increased sympathetic activation in PTSD subjects. Pearson correlations were conducted to assess the relationship between the PTSD severity scores and the various endocrine variables. The three IES subscales were correlated with several of the uncorrected and corrected hormone values (Table 4 ). All three IES subscales were significantly correlated with both the corrected and uncorrected epinephrine levels. Corrected values of norepinephrine also correlated significantly with the intrusion subscale (r = .34). In contrast, cortisol and 17-KS did not correlate directly with any of the IES scales. Similarly, correlations with two of the scales for depression (PAF: endogenous depression and organic depression) failed to reach statistical significance for any of the hormonal values.
infections, excessive discomfort with menstruation, and smoking. Sixty-two percent of the PTSDabused women vs. 18% of the PTSD+ women and 11% of the controls reported, vaginal infections (Fisher's exact test, df= 2, 6.44, p < .05). Sixty-four percent of the PTSD+ subjects and 75% of the PTSD-subjects reported excessive discomfort during menstruation, whereas only 22% of the controls reported excessive menstrual discomfort (Fisher's exact test, df = 2, 5.48, p = .06). This finding concurred with the data from the PAF.
Of the seven health-related behaviors measured by the SIGH, only incidence of smoking differed significantly. Forty-five percent of the PTSD+ subjects, but none of the other subjects, smoked (Fisher's exact test, df = 2, 9.41, p < .01). There were no significant differences on sleep duration or number of alcoholic beverages consumed per week. Similarly, there were no significant differences in the reported incidence of upper respiratory infections, colds, or flus within either the past 2 months or past year, or family history of major illness.
Health Profile An analysis of responses on the SIGH questionnaire indicated that significant group differences occurred on three measures: the incidence of vaginal
DISCUSSION
The present study verifies that abuse-related PTSD is accompanied by neuroendocrine activation as well as significant psychological disturbance. This sample of PTSD+ women had experienced childhood sexual abuse and evinced a severity of PTSD symptoms comparable to that seen in hospitalized male PTSD patients (44) . However, the pattern of neuroendocrine activation did not follow the pattern found in men after combat-related traumas: an elevation in catecholamines with normal or belownormal pituitary-adrenal activity. In contrast, this study suggests that PTSD+ women may have increased levels of both sympathetic and adrenocortical activation. Although not as pronounced, this activation of the adrenal cortex did extend to an increased secretion of adrenal androgens as reflected by a tendency for higher 17-KS in the urine. Urinary androgens and cortisol levels were significantly correlated, in keeping with the view that both hormones respond to pituitary ACTH secretion. Altered secretion of urinary androgens has been demonstrated in a variety of psychological conditions including stress, anorexia nervosa, and panic disorder (45) (46) (47) (48) .
The finding of increased cortisol and catecholamine output would concur with the findings on individuals showing PTSD reactions to natural disasters, such as the Three Mile Island nuclear reactor accident (49) . In interpreting their results, Baum and colleagues suggested that the chronic hormone effects might reflect the persistent intrusive nature of the memories and the continued sense of threat experienced by these individuals. These concepts may be particularly germane to PTSD related to sexual abuse, especially when the abusive experiences occurred at a young age, as is common in this population. Even in studies of combat veterans, it has been reported that elevated levels of cortisol may be observed at times when intrusive memories or psychopathology are reactivated (50, p. 289) .
In contrast, the correlational analysis between symptom severity and endocrine activation provided support for the suggestion that PTSD may be accompanied primarily by sympathetic, rather than endocrine, activation. Significant correlations between all three catecholamine measures (norepinephrine, epinephrine, dopamine) and PTSD severity were found, but neither measure of adrenocortical functioning (cortisol or 17-KS) was specifically related to psychological disturbance. Although cortisol levels were higher in the PTSD+ individuals, no significant correlations were found between depressive symptoms and any of the neuroendocrine variables. Similar correlations between catecholamines and severity of PTSD reaction to natural disasters and combat have been demonstrated (44, 51) . Some studies have suggested further that this activation of peripheral physiology in PTSD may be associated with increased monoaminergic activity in the central nervous system (52, 53) .
However, it should be reiterated that these findings reflected the convergent input of several factors that must be taken into account when evaluating urinary hormone values. Most significantly, the normal variation in body weight and urine excretion across subjects highlighted a number of variables that may influence the level of hormone found in a urine sample. Typically, these methodological concerns have been addressed by either determining the daily hormone output in 24-hour urine samples or by using a creatinine-adjusted value, but analyses from this study have indicated that these computations only partially compensate when urine volumes or body weight deviate markedly from the norm. Moreover, the finding of polyuria in several of the abused subjects may have serendipitously revealed an important physiological biomarker in this population. Their elevated urine volume could reflect high levels of liquid consumption, a pattern that has been noted in other forms of psychopathology (24) . Alternatively, their high urine output may be associated with the increased sympathetic activity found in this study. Catecholamines have been shown to affect diuresis, and, conversely, high rates of urine flow have been associated with changes in catecholamine output in the urine (54) . Studies using adrenergic receptor antagonism would be required to determine whether the increased diuresis in this population is associated with /3-adrenergic or a-adrenergic stimulation (55, 56) .
This report is not the first study to suggest that there may be a higher incidence of obesity in individuals with a history of sexual abuse (26, 27, 28) , but the current finding emphasizes the possible health significance of this type of comorbid status. The finding that 50% of the abused women were overweight is nearly double that of the national prevalence rate of 26% (57). In this small sample it is not possible to directly link their obesity with the abuse experienced during childhood, but there is some suggestion in the literature that increased stress and/or arousal facilitates eating in both animals and humans (58) . Studies in nonhuman primates have demonstrated that obesity is associated with elevated urinary catecholamine output in both the fed and food-deprived states and may indicate a predisposition for diabetes (59). Assessment of urinary glucose levels indicated that none of these subjects had frank diabetes, but the association between obesity, high urine volume, and elevated hormone levels may be suggestive of a preclinical diathesis preceding the emergence of diabetes. The
